![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SeekIn Receives CE Mark for its LeukoPrint Test for Leukemia
SeekIn Receives CE Mark for its LeukoPrint Test for Leukemia
Shenzhen, China-based SeekIn has received a CE mark for its LeukoPrint diagnostic kit for the detection of leukemia.
The kit uses whole-gene sequencing to identify gene alternations that are important for diagnostic classification and risk stratification in leukemia patients, the company said.
SeekIn, which specializes in blood-based cancer early-detection and monitoring technology, said LeukoPrint can also be used for other types of hematological malignancies, such as multiple myeloma.
Upcoming Events
-
21Oct